Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 2251 to 2260 of 2581 total matches.

Expanded Table: Some Available Insulins for Type 2 Diabetes (online only)

   
The Medical Letter on Drugs and Therapeutics • May 06, 2019  (Issue 1571)
Comparison Table: Some Available Insulins for Type 2 Diabetes Drug Concentrations Some ...
View the Expanded Table: Some Available Insulins
Med Lett Drugs Ther. 2019 May 6;61(1571):e73-7 |  Show IntroductionHide Introduction

Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms

   
The Medical Letter on Drugs and Therapeutics • Jul 01, 2019  (Issue 1575)
® Vol. 61 (1575) July 1, 2019 Table 1. Some Hormones for Menopausal Vasomotor Symptoms Drug Some ...
The FDA has approved Bijuva (TherapeuticsMD), a fixed-dose combination of estradiol and progesterone, for oral treatment of moderate to severe vasomotor symptoms (hot flashes) due to menopause in women with an intact uterus. The manufacturer is marketing Bijuva as "the first and only FDA-approved combination of bio-identical estradiol and bio-identical progesterone in a single daily oral capsule".
Med Lett Drugs Ther. 2019 Jul 1;61(1575):99-101 |  Show IntroductionHide Introduction

Adult Immunization

   
The Medical Letter on Drugs and Therapeutics • Oct 17, 2022  (Issue 1661)
. All rights reserved. ©2022. www.fdbhealth.com/policies/drug-pricing-policy. 17. The minimum interval between ...
The Advisory Committee on Immunization Practices (ACIP) recommends use of certain vaccines in adults residing in the US. Routine childhood immunization has reduced the overall incidence of some of these vaccine-preventable diseases, but many adults remain susceptible. Recommendations for vaccination against COVID-19, seasonal influenza, and monkeypox and vaccination of travelers have been reviewed separately.
Med Lett Drugs Ther. 2022 Oct 17;64(1661):161-8 |  Show IntroductionHide Introduction

Platelet-Derived Growth Factor for Diabetic Ulcers

   
The Medical Letter on Drugs and Therapeutics • Jul 17, 1998  (Issue 1031)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Becaplermin (be kap' ler min; Regranex - Ortho-McNeil), a 0.01% topical gel formulation of recombinant human platelet-derived growth factor (rhPDGF), was recently approved by the FDA for adjunctive treatment of diabetic ulcers of the lower extremities that extend subcutaneously or beyond and have an adequate blood supply. Endogenous platelet-derived growth factor increases proliferation of cells that repair wounds and form granulation tissue.
Med Lett Drugs Ther. 1998 Jul 17;40(1031):73-4 |  Show IntroductionHide Introduction

In Brief: Propofol Revisited

   
The Medical Letter on Drugs and Therapeutics • Oct 17, 2011  (Issue 1375)
The Medical Letter® On Drugs and Therapeutics Volume 53 (Issue 1375) October 17, 2011 ...
A reader has asked us to review the use of propofol (Diprivan, and others) as a sedative agent for brief procedures, such as colonoscopy.First marketed more than 20 years ago,1 propofol has a rapid onset of action (patients usually lose consciousness in less then one minute) and a short duration of action with a rapid recovery (3-5 minutes) that makes it highly suitable for brief ambulatory procedures. Propofol is now the most commonly used parenteral anesthetic in the US.2 The main problems with its use have been pain on injection and bacterial contamination, both related to its lipid...
Med Lett Drugs Ther. 2011 Oct 17;53(1375):84 |  Show IntroductionHide Introduction

In Brief: Calcium and Vitamin D to Prevent Osteoporotic Fractures

   
The Medical Letter on Drugs and Therapeutics • Jun 25, 2012  (Issue 1393)
The Medical Letter® On Drugs and Therapeutics Volume 54 (Issue 1393) June 25, 2012 ...
The US Preventive Services Task Force (USPSTF) has issued a Draft Recommendation Statement saying, in effect, that community-dwelling women and men should not take calcium and vitamin D supplements for primary prevention of osteoporotic fractures because the evidence that they are helpful is insufficient and they increase the risk of kidney stones. The Medical Letter has said previously that there is no evidence that patients with an adequate intake of calcium (1000-1200 mg/day) and vitamin D (600-800 IU/day) will benefit from taking supplements.11. Drugs for postmenopausal osteoporosis. Treat...
Med Lett Drugs Ther. 2012 Jun 25;54(1393):52 |  Show IntroductionHide Introduction

In Brief: Two New Seasonal Influenza Vaccines

   
The Medical Letter on Drugs and Therapeutics • Feb 04, 2013  (Issue 1409)
The Medical Letter® On Drugs and Therapeutics Volume 55 (Issue 1409) February 4, 2013 ...
Two new trivalent influenza vaccines, Flucelvax (Novartis) and Flublok (Protein Sciences), will soon be available for prevention of seasonal influenza in adults ≥18 years old (Flucelvax) and 18-49 years old (Flublok). Unlike other available influenza vaccines, neither vaccine is produced in eggs, removing any concern regarding use in egg-allergic patients. Avoiding the use of eggs should allow for faster production of these 2 new vaccines, which could be especially beneficial during a pandemic.Flucelvax is prepared in a similar manner to other influenza vaccines, but the influenza virus is...
Med Lett Drugs Ther. 2013 Feb 4;55(1409):12 |  Show IntroductionHide Introduction

Treatment of COVID-19 in High-Risk Outpatients (online only)

   
The Medical Letter on Drugs and Therapeutics • Jan 28, 2022  (Issue 1643)
-Pugh C), patients taking strong CYP3A inducers4 or high-risk, highly CYP3A-dependent drugs (e.g ...
View the Treatment of COVID-19 in High-Risk Outpatients Chart
Med Lett Drugs Ther. 2022 Jan 28;64(1643):e1 |  Show IntroductionHide Introduction

In Brief: Oral Minoxidil for Hair Loss

   
The Medical Letter on Drugs and Therapeutics • Dec 26, 2022  (Issue 1666)
with an oral antiandrogenic drug such as spironolactone.1 Oral minoxidil, which is available by prescription ...
Topical minoxidil (Rogaine, and others), which is available over the counter, has been used for treatment of hair loss in men and women for more than 30 years. Recently published trials suggest that off-label use of a low dose of oral minoxidil may also be effective.
Med Lett Drugs Ther. 2022 Dec 26;64(1666):208 |  Show IntroductionHide Introduction

Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 17, 2025  (Issue 1722)
Drug/Formulations Class Approved Age Efficacy at 16 Weeks1 Usual Adult Dosage Cost2 Dupilumab ...
View the Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis
Med Lett Drugs Ther. 2025 Feb 17;67(1722):e1   doi:10.58347/tml.2025.1722f |  Show IntroductionHide Introduction